{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:41:20Z","timestamp":1777311680038,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00889-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:55:14Z","timestamp":1777308914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Inhaled GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"204","author":[{"given":"Mehak","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashray","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdrabo Gamal","family":"Motawea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahithi Mani Chandana","family":"Paramkusam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Pelumi","family":"Fatukasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav Vardhan","family":"Paramkusam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Ganduboina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosana","family":"Candreva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra Prasad","family":"Shivaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"23","key":"889_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM195806052582301","volume":"258","author":"SH Rosen","year":"1958","unstructured":"Rosen SH, Castleman B, Liebow AA (1958) Pulmonary alveolar proteinosis. N Engl J Med 258(23):1123\u20131142. https:\/\/doi.org\/10.1056\/NEJM195806052582301","journal-title":"N Engl J Med"},{"issue":"9","key":"889_CR2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","volume":"205","author":"C McCarthy","year":"2022","unstructured":"McCarthy C, Carey BC, Trapnell BC (2022) Autoimmune pulmonary alveolar proteinosis. Am J Respir Crit Care Med 205(9):1016\u20131035. https:\/\/doi.org\/10.1164\/rccm.202112-2742SO","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"889_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0018-2020","volume":"16","author":"E Salvaterra","year":"2020","unstructured":"Salvaterra E, Campo I (2020) Pulmonary alveolar proteinosis: from classification to therapy. Breathe Sheff 16(2):200018. https:\/\/doi.org\/10.1183\/20734735.0018-2020","journal-title":"Breathe Sheff"},{"issue":"2","key":"889_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0224-2024","volume":"21","author":"T Alfaro","year":"2025","unstructured":"Alfaro T, McCarthy C, Bonella F, Bendstrup E, O\u2019Callaghan M (2025) Summary for clinicians: ERS guidelines on pulmonary alveolar proteinosis. Breathe Sheff 21(2):240224. https:\/\/doi.org\/10.1183\/20734735.0224-2024","journal-title":"Breathe Sheff"},{"issue":"10","key":"889_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s40265-025-02228-3","volume":"85","author":"S Jouneau","year":"2025","unstructured":"Jouneau S, Chauvin P, Lederlin M, Painvin B, Kerjouan M (2025) Pharmacotherapy for autoimmune pulmonary alveolar proteinosis. Drugs 85(10):1193\u20131206. https:\/\/doi.org\/10.1007\/s40265-025-02228-3","journal-title":"Drugs"},{"issue":"1","key":"889_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01233-2023","volume":"63","author":"I Campo","year":"2024","unstructured":"Campo I, Carey BC, Paracchini E, Kadija Z, De Silvestri A, Rodi G, De Amici M, Torre C, Zorzetto M, Griese M, Meloni F, Corsico AG, Trapnell BC, Mariani F (2024) Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients. Eur Respir J 63(1):2301233. https:\/\/doi.org\/10.1183\/13993003.01233-2023","journal-title":"Eur Respir J"},{"key":"889_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"889_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"889_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3900","volume":"371","author":"R Brignardello-Petersen","year":"2020","unstructured":"Brignardello-Petersen R, Florez ID, Izcovich A, Santesso N, Hazlewood G, Alhazanni W, Yepes-Nu\u00f1ez JJ, Tomlinson G, Sch\u00fcnemann HJ, Guyatt GH, GRADE working group (2020) GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework. BMJ 371:m3900. https:\/\/doi.org\/10.1136\/bmj.m3900","journal-title":"BMJ"},{"issue":"11","key":"889_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"17","key":"889_CR11","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1056\/NEJMoa1913590","volume":"383","author":"BC Trapnell","year":"2020","unstructured":"Trapnell BC, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, Campo I, Papiris SA, Yamaguchi E, Cetinkaya E, Ilkovich MM, Kramer MR, Veltkamp M, Kreuter M, Baba T, Ganslandt C, Tarnow I, Waterer G, Jouhikainen T, IMPALA Trial Investigators (2020) Inhaled Molgramostim therapy in autoimmune pulmonary alveolar proteinosis. N Engl J Med 383(17):1635\u20131644. https:\/\/doi.org\/10.1056\/NEJMoa1913590","journal-title":"N Engl J Med"},{"issue":"1","key":"889_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01450-4","volume":"15","author":"X Tian","year":"2020","unstructured":"Tian X, Yang Y, Chen L, Sui X, Xu W, Li X, Guo X, Liu L, Situ Y, Wang J, Zhao Y, Meng S, Song W, Xiao Y, Xu KF (2020) Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24\u2009months of follow-up. Orphanet J Rare Dis 15(1):174. https:\/\/doi.org\/10.1186\/s13023-020-01450-4","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"889_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1816216","volume":"381","author":"R Tazawa","year":"2019","unstructured":"Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K (2019) Inhaled GM-CSF for pulmonary alveolar proteinosis. N Engl J Med 381(10):923\u2013932. https:\/\/doi.org\/10.1056\/NEJMoa1816216","journal-title":"N Engl J Med"},{"issue":"8","key":"889_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1056\/NEJMoa2410542","volume":"393","author":"BC Trapnell","year":"2025","unstructured":"Trapnell BC, Inoue Y, Bonella F, Wang T, McCarthy C, Arai T, Akasaka K, Mariani F, Mogulkoc N, Song JW, Baba T, Jouneau S, Numakura T, \u00d6cal N, Mihaltan F, Ataya A, Bendstrup E, Campo I, Carey B, Arena R, Robinson B, Fleming R, Wasfi Y, Pratt R, IMPALA-2 Trial Investigators (2025) Phase 3 trial of inhaled Molgramostim in autoimmune pulmonary alveolar proteinosis. N Engl J Med 393(8):764\u2013773. https:\/\/doi.org\/10.1056\/NEJMoa2410542","journal-title":"N Engl J Med"},{"issue":"26","key":"889_CR15","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1056\/NEJMra023226","volume":"349","author":"BC Trapnell","year":"2003","unstructured":"Trapnell BC, Whitsett JA, Nakata K (2003) Pulmonary alveolar proteinosis. N Engl J Med 349(26):2527\u20132539. https:\/\/doi.org\/10.1056\/NEJMra023226","journal-title":"N Engl J Med"},{"issue":"6","key":"889_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa062505","volume":"356","author":"K Uchida","year":"2007","unstructured":"Uchida K, Beck DC, Yamamoto T, Berclaz PY, Abe S, Staudt MK, Carey BC, Filippi MD, Wert SE, Denson LA, Puchalski JT, Hauck DM, Trapnell BC (2007) GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 356(6):567\u2013579. https:\/\/doi.org\/10.1056\/NEJMoa062505","journal-title":"N Engl J Med"},{"issue":"2","key":"889_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1164\/rccm.2109105","volume":"166","author":"JF Seymour","year":"2002","unstructured":"Seymour JF, Presneill JJ (2002) Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166(2):215\u2013235. https:\/\/doi.org\/10.1164\/rccm.2109105","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"889_CR18","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.rmed.2011.08.018","volume":"105","author":"F Bonella","year":"2011","unstructured":"Bonella F, Bauer PC, Griese M, Ohshimo S, Guzman J, Costabel U (2011) Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Respir Med 105(12):1908\u20131916. https:\/\/doi.org\/10.1016\/j.rmed.2011.08.018. (Epub 2011 Sep 6)","journal-title":"Respir Med"},{"issue":"6","key":"889_CR19","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ (2014) An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 44(6):1428\u20131446. https:\/\/doi.org\/10.1183\/09031936.00150314","journal-title":"Eur Respir J"},{"issue":"1","key":"889_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1081\/copd-200050513","volume":"2","author":"PW Jones","year":"2005","unstructured":"Jones PW (2005) St. George\u2019s Respiratory Questionnaire: MCID. COPD 2(1):75\u201379. https:\/\/doi.org\/10.1081\/copd-200050513","journal-title":"COPD"},{"issue":"170","key":"889_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0080-2023","volume":"32","author":"M Munsif","year":"2023","unstructured":"Munsif M, Sweeney D, Leong TL, Stirling RG (2023) Nebulised granulocyte-macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis. Eur Respir Rev 32(170):230080. https:\/\/doi.org\/10.1183\/16000617.0080-2023","journal-title":"Eur Respir Rev"},{"issue":"1","key":"889_CR22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01233-2023","volume":"63","author":"I Campo","year":"2024","unstructured":"Campo I, Carey BC, Paracchini E, Kadija Z, De Silvestri A, Rodi G, De Amici M, Torre C, Zorzetto M, Griese M, Meloni F, Corsico AG, Trapnell BC, Mariani F (2024) Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients. Eur Respir J 63(1):2301233. https:\/\/doi.org\/10.1183\/13993003.01233-2023","journal-title":"Eur Respir J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00889-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00889-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00889-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:55:15Z","timestamp":1777308915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00889-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00889-9","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required for this study, as it is a systematic review and meta-analysis of previously published data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}],"article-number":"23"}}